Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...

New Summit Bio to be China Partner for Pacgen’s Thrush Treatment

publication date: Jan 28, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
New Summit Biopharma Company of Shanghai has struck a deal with Pacgen Biopharmaceuticals of Vancouver, Canada to develop a treatment for oral candidiasis for commercialization in China. New Summit Bio will collaborate with Pacgen to raise funding and to develop the anti-fungal compound, PAC-113, for China. More details...

Stock Symbol: (TSX VENTURE: PGA)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners